Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

Nature Medicine
P DullforceA W Heath

Abstract

In this report we describe a potentially powerful method for vaccinating infants against encapsulated bacterial pathogens such as Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis. High levels of antibody directed against the polysaccharides of the bacterial capsule are normally protective. Unfortunately, the capsular polysaccharides are T cell-independent antigens (TI); lacking T-cell help, they induce only weak, predominantly IgM antibody responses, with infants responding especially poorly. T-cell help, given to B cells during responses to protein antigens, causes stronger antibody responses and isotype switching to the IgG isotypes. T-cell help is mainly mediated through ligation of the B-cell surface antigen, CD40, by its cognate T-cell ligand, CD154. Here we show that administering anti-CD40 monoclonal antibody to mice, along with pneumococcal polysaccharide, provides a substitute for T-cell help and results in the generation of strong, isotype-switched antibody responses, which are protective. The work points the way toward a possible effective and inexpensive means of protecting susceptible groups against important bacterial pathogens.

References

May 7, 1992·Nature·R J ArmitageC R Maliszewski
Nov 1, 1991·Science·R KühnW Müller
Jul 1, 1983·The Journal of Infectious Diseases·R M DouglasD J Hansman
Mar 1, 1981·Reviews of Infectious Diseases·S H Landesman, G Schiffman
Jan 1, 1994·European Journal of Immunology·M K KennedyK H Grabstein
Jan 1, 1994·European Journal of Immunology·J Hasbold, G G Klaus
Aug 1, 1994·European Journal of Immunology·A W HeathM C Howard
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·E CastigliR S Geha
Jan 1, 1995·Annual Review of Immunology·J J MondC M Snapper
Sep 1, 1993·European Journal of Immunology·R J ArmitageM R Alderson
Aug 1, 1994·Immunity·J XuR A Flavell
Nov 1, 1994·The Journal of Experimental Medicine·B R RenshawC R Maliszewski
Jan 1, 1993·Advances in Immunology·R L CoffmanP Rothman
Dec 1, 1996·European Journal of Immunology·W G FerlinM C Howard

❮ Previous
Next ❯

Citations

Oct 30, 1999·European Journal of Immunology·C García de VinuesaG G Klaus
Nov 11, 1999·European Journal of Immunology·C García De VinuesaI C MacLennan
Aug 14, 2001·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·P W Johnson
Aug 29, 2002·Clinical and Experimental Immunology·S JollesA Ager
Sep 21, 2011·Glycobiology·Michiko N Fukuda
Dec 16, 1998·Xenotransplantation·M Koulmanda, H Auchincloss
Mar 23, 2006·Annual Review of Immunology·Flavius Martin, Andrew C Chan
Mar 6, 2002·The Journal of Clinical Investigation·Loren D EricksonRandolph J Noelle
Jan 15, 2005·The Journal of Clinical Investigation·Helen M MarriottDavid H Dockrell
Mar 9, 2010·Journal of Immune Based Therapies and Vaccines·Vijay Ns Bhagawati-PrasadAndrew W Heath
Mar 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Thomas R KozelC Rick Lyons
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sacha GnjaticLloyd J Old
Jul 6, 2010·Developmental and Comparative Immunology·Chang-Hsin ChenLuc R Berghman
May 12, 2009·Immunological Reviews·Mandy L Ford, Christian P Larsen
Nov 12, 2009·BioFactors·Antonios ChatzigeorgiouElli Kamper
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C P LarsenA D Kirk
Jan 13, 2012·Clinical and Experimental Immunology·L G DurrantI Spendlove
Mar 2, 2006·The American Journal of Pathology·Kiminori KimuraFrancis V Chisari
May 24, 2001·Immunity·G U von BülowR J Bram
Mar 15, 2006·Vaccine·Tom A BarrAndrew W Heath
Aug 6, 2005·Journal of Leukocyte Biology·Michaël BoudewijnsXavier Bossuyt
Mar 8, 2007·Nature Medicine·John B A G Haanen, Ton N M Schumacher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.